HighTower Advisors
ZBH icon

HighTower Advisors’s Zimmer Biomet ZBH Stock Holding History

HighTower Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-309
Closed -$1K – 2439
2018
Q2 		$1K Buy
+309
New +$33.6K ﹤0.01% 2229

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

HighTower Advisors's ZBH Position: Q2 2026 in Review

HighTower Advisors reduced its Zimmer Biomet (ZBH) stake by 5.3% in Q2 2026, selling an estimated $96.7K and leaving 19,571 shares worth $1.68M. The position accounts for ﹤0.01% of the portfolio, ranked #1879.

HighTower Advisors first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $20.8M in Q1 2024. 910 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • HighTower Advisors held 19,571 shares of Zimmer Biomet worth $1.68M as of Q2 2026.
  • HighTower Advisors sold 1,103 Zimmer Biomet shares in Q2 2026, an estimated $96.7K.
  • Zimmer Biomet made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #1879 holding.
  • HighTower Advisors first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
  • HighTower Advisors's Zimmer Biomet position peaked at $20.8M in Q1 2024.
  • 910 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.